title: Pathophysiology of fatty acid oxidation disorders.
abstract: Mitochondrial fatty acid oxidation represents an important pathway for energy generation during periods of increased energy demand such as fasting, febrile illness and muscular exertion. In liver, the primary end products of the pathway are ketone bodies, which are released into the circulation and provide energy to tissues that are not able to oxidize fatty acids such as brain. Other tissues, such as cardiac and skeletal muscle are capable of direct utilization of the fatty acids as sources of energy. This article provides an overview of the pathogenesis of fatty acid oxidation disorders. It describes the different tissue involvement with the disease processes and correlates disease phenotype with the nature of the genetic defect for the known disorders of the pathway.
authors.affiliation: Department of Pathology & Laboratory Medicine, University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. bennettmi@email.chop.edu
authors.forename: M J
authors.initials: MJ
authors.lastname: Bennett
mesh_terms: D000818:Animals; D004734:Energy Metabolism / Q000235:genetics; D005227:Fatty Acids / Q000378:metabolism*; D005838:Genotype; D006801:Humans; D008052:Lipid Metabolism, Inborn Errors / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology*; D008928:Mitochondria / Q000201:enzymology*; D028361:Mitochondrial Diseases / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology*; D010084:Oxidation-Reduction; D010641:Phenotype
chemical_list: D005227:Fatty Acids
references.citation: Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1098-105
references.pmid: 12582009
references.citation: Mol Genet Metab. 2009 Apr;96(4):201-7
references.pmid: 19217814
references.citation: Biochem Biophys Res Commun. 2008 Mar 28;368(1):6-11
references.pmid: 18036338
references.citation: J Clin Endocrinol Metab. 2009 Jul;94(7):2221-5
references.pmid: 19417036
references.citation: Hum Genet. 2008 Aug;124(1):43-56
references.pmid: 18523805
references.citation: J Lipid Res. 2001 Jul;42(7):1134-42
references.pmid: 11441142
references.citation: Pediatrics. 2002 Jan;109(1):99-104
references.pmid: 11773547
references.citation: Annu Rev Physiol. 2002;64:477-502
references.pmid: 11826276
references.citation: Mol Genet Metab. 2007 Dec;92(4):315-24
references.pmid: 17884651
references.citation: Mol Genet Metab. 2008 Dec;95(4):241-2
references.pmid: 18951053
references.citation: Lancet. 2007 Jan 6;369(9555):37-42
references.pmid: 17208640
references.citation: J Inherit Metab Dis. 2006 Feb;29(1):71-5
references.pmid: 16601871
references.citation: Genomics. 2002 Oct;80(4):433-42
references.pmid: 12376098
references.citation: N Engl J Med. 1998 May 7;338(19):1352-7
references.pmid: 9571255
references.citation: Eur J Biochem. 1997 Feb 15;244(1):1-14
references.pmid: 9063439
references.citation: Ophthalmology. 1998 May;105(5):810-24
references.pmid: 9593380
references.citation: J Pediatr. 2005 May;146(5):706-8
references.pmid: 15870679
references.citation: Lancet. 1993 Feb 13;341(8842):407-8
references.pmid: 8094173
references.citation: Diabetes. 2004 Jan;53(1):221-7
references.pmid: 14693719
references.citation: Hum Mutat. 2003 May;21(5):493-501
references.pmid: 12673791
references.citation: J Clin Invest. 2001 Aug;108(3):457-65
references.pmid: 11489939
references.citation: Pediatr Res. 1989 Jan;25(1):38-43
references.pmid: 2919115
references.citation: J Pediatr. 1994 Mar;124(3):409-15
references.pmid: 8120710
references.citation: J Inherit Metab Dis. 2003;26(6):543-57
references.pmid: 14605500
references.citation: Mol Genet Metab. 2006 Sep-Oct;89(1-2):74-9
references.pmid: 16725361
references.citation: Mol Genet Metab. 2008 Dec;95(4):195-200
references.pmid: 18977676
references.citation: Mol Genet Metab. 2001 Mar;72(3):265-8
references.pmid: 11243734
references.citation: N Engl J Med. 1999 Jun 3;340(22):1723-31
references.pmid: 10352164